← back to search

James W. Ironside

Medical Research Council · GB
Area of research
Molecular Biology · Neurology
Research interest
Research interests include Prion Diseases and Protein Misfolding, Neurological diseases and metabolism, Trace Elements in Health, and Glioma Diagnosis and Treatment.
h-index
91
citations
37,418
works
748
NIH funding
primary concept
email

Recent publications

High-Depth PRNP Sequencing in Brains With Sporadic Creutzfeldt-Jakob Disease.
2023cited by 5position: contributordoi
Serpin Signatures in Prion and Alzheimer's Diseases.
2022cited by 65position: contributordoi
Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients.
2021cited by 17position: contributordoi
Association of baseline hematoma and edema volumes with one-year outcome and long-term survival after spontaneous intracerebral hemorrhage: A community-based inception cohort study.
2021cited by 10position: contributordoi
Prion strains associated with iatrogenic CJD in French and UK human growth hormone recipients.
2021cited by 8position: contributordoi
Prevalence in Britain of abnormal prion protein in human appendices before and after exposure to the cattle BSE epizootic.
2020cited by 28position: contributordoi
Prions from Sporadic Creutzfeldt-Jakob Disease Patients Propagate as Strain Mixtures.
2020cited by 26position: contributordoi
Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates.
2020cited by 15position: contributordoi
Spinal subependymoma surgery: do no harm. Little may be more!
2020cited by 7position: contributordoi
Convalescent plasma for administration of passive antibodies against viral agents.
2020cited by 2position: contributordoi
Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.
2020cited by 2position: contributordoi
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
Acta Neuropathologica 2019cited by 130position: middledoi
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.
2019cited by 105position: contributordoi
Frequency and signature of somatic variants in 1461 human brain exomes.
2019cited by 24position: contributordoi
Variably protease-sensitive prionopathy mimicking frontotemporal dementia.
2019cited by 9position: contributordoi
Frequency and signature of somatic variants in 1461 human brain exomes
Genetics in Medicine 2018cited by 32position: middledoi
A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report
European Journal of Cancer 2017cited by 150position: middledoi
Prion seeding activity and infectivity in skin samples from patients with sporadic Creutzfeldt-Jakob disease
Science Translational Medicine 2017cited by 145position: middledoi
Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains
Acta Neuropathologica Communications 2017cited by 135position: middledoi
Human stem cell–derived astrocytes replicate human prions in a <i>PRNP</i> genotype–dependent manner
The Journal of Experimental Medicine 2017cited by 89position: middledoi
Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment
Brain 2016cited by 313position: middledoi
Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection
Acta Neuropathologica Communications 2016cited by 101position: middledoi
Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study
Alzheimer s & Dementia 2015cited by 602position: middledoi
Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy
Acta Neuropathologica 2015cited by 522position: middledoi
BrainNet Europe’s Code of Conduct for brain banking
Journal of Neural Transmission 2015cited by 66position: middledoi
Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders
Blood Reviews 2015cited by 45position: lastdoi
Neuropathological assessments of the pathology in frontotemporal lobar degeneration with TDP43-positive inclusions: an inter-laboratory study by the BrainNet Europe consortium
Journal of Neural Transmission 2014cited by 36position: middledoi
Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA
Acta Neuropathologica 2012cited by 231position: middledoi
Neuropathology of the hippocampus in FTLD‐Tau with Pick bodies: a study of the BrainNet Europe Consortium
Neuropathology and Applied Neurobiology 2012cited by 72position: middledoi
The need to unify neuropathological assessments of vascular alterations in the ageing brain
Experimental Gerontology 2012cited by 65position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Safa Al‐Sarraj · King's College London4 papers (2012–2018)Claire Troakes · King's College London3 papers (2012–2018)Colin Smith · Mott MacDonald (United Kingdom)3 papers (2016–2018)Johannes Attems · Newcastle University3 papers (2016–2018)Olaf Ansorge · Ludwig-Maximilians-Universität München3 papers (2012–2018)Margaret M. Esiri · Ludwig-Maximilians-Universität München2 papers (2012–2016)Kevin Talbot · University of California, San Francisco2 papers (2017–2018)Isidró Ferrer · Università Campus Bio-Medico2 papers (2012–2012)Gábor G. Kovács · University Health Network2 papers (2012–2012)Patrick F. Chinnery · University of Dundee2 papers (2017–2018)Annemieke J.M. Rozemüller · Utrecht University2 papers (2012–2012)Nick S. Jones · United Kingdom Atomic Energy Authority2 papers (2018–2019)Mark L. Cohen · University School2 papers (2012–2017)Giorgio Giaccone · University of California System2 papers (2012–2012)Michael J. Keogh · Cambridge University Hospitals NHS Foundation Trust2 papers (2017–2018)Danielle Seilhean · Institut Pasteur2 papers (2012–2015)Martin R. Turner · University of Oxford2 papers (2017–2018)Ian Wilson · Newcastle University2 papers (2017–2018)Ellen Gelpí · Université Claude Bernard Lyon 12 papers (2012–2012)Tibor Hortobágyi · University Hospital of Zurich2 papers (2012–2016)